Keytruda 25 mg

KEYTRUDA 25 MG is a solution for intravenous use, containing the active ingredient pembrolizumab. This medication is used in cancer treatment to help the immune system fight cancer cells. It is manufactured by Merck Canada Inc. and is available in a 4 mL pack size.

KEYTRUDA 25 MG is primarily used in the treatment of various types of cancer. It works by helping the immune system recognize and attack cancer cells. This medication is often used in combination with other cancer treatments to improve outcomes. What is KEYTRUDA used for? It is commonly prescribed for advanced or metastatic cancers that have spread to other parts of the body.

Common effects of KEYTRUDA 25 MG may include fatigue, cough, nausea, and itching. Some patients may experience more severe side effects, such as difficulty breathing or swelling. It is important to discuss any unusual symptoms with a healthcare provider. The effects of KEYTRUDA can vary from person to person.

KEYTRUDA 25 MG should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Proper storage and handling are crucial to maintain the effectiveness of the medication.

KEYTRUDA 25 MG may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain foods may also affect the effectiveness of KEYTRUDA. Always consult with a healthcare professional before starting any new medication.